Navigation Links
Accera, Inc. Announces Results of Phase II Study in Alzheimer's,Disease at American Academy of Neurology Meeting

BROOMFIELD, Colo., May 01, 2007 /PRNewswire/ -- Accera Inc. is presenting topline data today from its Phase IIb study of its lead compound AC-1202 in Alzheimer's disease (AD) at the American Academy of Neurology (AAN) 59th Annual Meeting in Boston. Judged by the AAN to be in the top five percent of the program, the data will also be featured in the Scientific Highlights Plenary Session.

The randomized, double-blinded, placebo-controlled Phase IIb trial evaluated 152 subjects that had previously been diagnosed with mild to moderate AD. Consistent with the findings of Accera's Phase IIa study, subjects who did not have the ApoE4 genotype-a known genetic risk factor that occurs in half of all AD patients-responded particularly well to treatment, as reflected in statistically significant improvement in AD Assessment Scale- Cognitive (ADAS-Cog) scores.

Subjects underwent pharmacogenomic analysis for a variety of genetic markers and were evaluated through a battery of neuropsychometric tests at Day 0, 45, and 90. Compared to the placebo group, the ADAS-Cog scores of the AC- 1202-treated ApoE4(-) population improved 3.5 points in twelve weeks (p=0.01), and statistically significant improvement was seen in just 45 days.

Interestingly, ApoE4(-) subjects who also exhibited a genetic variation that affects glucose regulation showed a 5 point improvement in ADAS-Cog scores compared to placebo, providing further insight into the disease. "The profound effect we see in the population without the ApoE4 risk factor supports the findings of an earlier study linking efficacy to a certain pharmacogenomic profile," said Dr. Lauren Costantini, Accera's vice president of clinical development. "It also provides further evidence of the link between Alzheimer's disease and glucose metabolism."

Regardless of genotype, subjects treated with AC-1202 showed a trend toward improvement (p=.072), suggesting the com
'"/>




Page: 1 2 3

Related medicine technology :

1. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
2. Accera, Inc. to Present Results of Phase II Study in Alzheimers Disease at American Academy of Neurology Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
(Date:9/17/2014)... 2014  Millions of people suffer from neck and arm ... Recently the FDA approved the launch of a clinical ... device developed by Spinal Kinetics, which may offer relief to ... arm pain. Hospital for Special Surgery (HSS), the number one ... New York City and in the ...
(Date:9/17/2014)... Texas , Sept. 17, 2014  Lightbeam ... Direct Accountable Care Organization (Physician Direct ACO) to ... their physicians in providing better care while reducing ... Physician Direct Accountable Care Organization ... Network Services (OPNS). The OPNS mission is to ...
(Date:9/17/2014)... COLUMBUS, Ohio , Sept. 17, 2014 /PRNewswire/ ... Riverside Radiology and Interventional Associates announced today ... Systems to enhance its image sharing capabilities ... case of any network failures. In addition, the ... to help navigate disparate PACS systems to more ...
Breaking Medicine Technology:Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3
... N.J., Oct. 27 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed a new drug application under Section ... (FFDCA) with the U.S. Food and Drug Administration (FDA) ... and 40 mg tablets.  Watson,s rosuvastatin zinc tablets are ...
... Oct. 27 Intrinsic Bioprobes today announced that ... issued US Patent 7,816,095 covering novel blood protein ... first of a series of patent applications that ... clinical utility. "The biomarkers were discovered ...
Cached Medicine Technology:Watson Confirms Crestor® Patent Challenge 2Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction 2
(Date:9/17/2014)... 17, 2014 In a continuing effort ... Nile virus threats, Mosquito Shield of the South Shore ... with the Hanover Youth Athletic Association to treat area ... daily practices going until dusk, prime mosquito feeding time, ... athletes, coaches, and parents involved in outdoor athletic activities. ...
(Date:9/17/2014)... 2014 Stand Up for Heroes, New ... to the Theater at Madison Square Garden, Wednesday, Nov. ... Foundation (BWF) and New York Comedy Festival (NYCF), the ... veterans and their families. , The charitable event ... Oliver, Bruce Springsteen, Brian Williams and other surprise guests. ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Health ... increase efficiency. Today, Pharmacy Healthcare Solutions, a wholly ... web-based analysis and forecasting tool that enables hospitals ... the impact of medications on improved patient outcomes. ... uses pharmacy purchase data to identify areas of ...
(Date:9/17/2014)... 16, 2014) A study led by St. Jude ... dose threshold below which male childhood cancer survivors ... study appears in September 17 edition of the ... which patients are at highest risk for reduced ... to eventually increase use of pre-treatment fertility preservation ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 MarijuanaStock.net, ... http://www.marijuanastock.net , recently launched a “Video” section that ... cannabis companies in the marijuana industry made available ... a website visitor is given access to numerous ... to marijuana-related businesses and the issues they face. ...
Breaking Medicine News(10 mins):Health News:Mosquito Shield of South Shore Again Partners with Hanover Youth Athletic Association 2Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 2Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 3Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 4Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 5Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 2Health News:Pharmacy Healthcare Solutions Launches TARxGET™ Reporting 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3Health News:MarijuanaStock.net Adds Business News Video Section to Their Website 2
... drilling, new energy technologies, science at the LHC, tests of gravity ... edge science will be featured in talks at this year,s April ... April 30 to May 3 at the Hyatt Hotel Orange County ... free of charge. Registration information can be found at the end ...
... be at increased risk of damage to the same brain ... by researchers at Washington University School of Medicine in St. ... that scientists have linked to neurological problems including Parkinson,s disease-like ... than 1 million workers who perform welding as a part ...
... the School of Public Health at the University of ... of depression may have long-term benefits. The data ... a longitudinal Canadian study, and showed depressed adults who ... depressed eight years later, compared to depressed adults who ...
... , WEDNESDAY, April 6 (HealthDay News) -- Long-term users ... damage, warns a new study. Brain scans showed an ... and a lower proportion of overall gray matter among long-term ... that people who use ecstasy can develop serious memory problems, ...
... THURSDAY, April 7 (HealthDay News) -- For American parents, doctors ... of children,s vaccines, a new study indicates. Researchers conducted ... and younger, and found that 76 percent said they trusted ... information about vaccine safety. Other sources trusted "a lot" ...
... (HealthDay News) -- A new report reveals that 98.8 percent ... to 64 with untreated alcohol abuse disorders don,t believe they ... nearly 6 million American adults with untreated alcohol dependence recognize ... to increase public awareness about adult problem drinking, how to ...
Cached Medicine News:Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 2Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 3Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 4Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 5Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 6Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 7Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 8Health News:Welders may be at increased risk for brain damage 2Health News:Treatment for depression a long-term solution 2Health News:Long-Term Ecstasy Users at Risk for Brain Damage, Study Warns 2Health News:Doctors Most Trusted Source of Vaccine Information, Study Finds 2Health News:Only 1.2% of Alcohol Abusers Know They Need Help: Report 2
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... Aspen® CTO combines highly effective immobilization of ... a level of comfort that makes it ... substantially progressive immobilization in going from a ... and then on to a four-post orthosis. ...
... Shoulder Immobilizer with Contoured ... Navy cotton sling with foam-padded ... body straps. Quick-release closure buckles. ... 35 covered abduction wedge to ...
The Humeral Stabilizing System is a terrific option for immobilization of stable humeral fractures, stablesupracondular fractures, and biceps/triceps repairs....
Medicine Products: